Emerging concepts in epithelial ovarian cancer: Highlights of the 4 th Canadian Conference on Ovarian Cancer Research

European Journal of Gynaecological Oncology

Volumn 30, Issue 6, 2009, Pages 625-630

  Tone, A A ^a,b   Letarte, M ^a,c,d   Brown, T J ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Canadian conference; Etiology; Ovarian cancer; Risk factors; Treatment

Indexed keywords

CARBOPLATIN; CEDIRANIB; CISPLATIN; ERLOTINIB; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N ACETYLSARCOSYLGLYCYLVALYL DEXTRO ALLOISOLEUCYLTHREONYLNORVALYLISOLEUCYLARGINYLPROLINE ETHYLAMIDE; TOPOTECAN;

CANCER RESEARCH; CANCER RISK; CONFERENCE PAPER; HUMAN; NONHUMAN; OVARY CANCER; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR;

ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RISK FACTORS;

EID: 70949090838     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Tworoger S.S., Gertig D.M., Gates M.A., Hecht J.L., Hankinson S.E.: "Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer". Cancer, 2008, 112, 1169.
2. Kobel M., Huntsman D., Gilks C.B.: "Critical molecular abnormalities in high-grade serous carcinoma of the ovary". Expert Rev. Mol. Med., 2008, 10, e22.
3. Kobel M., Kalloger S.E., Carrick J., Huntsman D., Asad H., Oliva E. et al.: "A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary". Am. J. Surg. Pathol., 2008.
4. Fathalla M.F.: "Incessant ovulation-a factor in ovarian neoplasia?". Lancet, 1971, 2, 163.
5. Press J.Z., Kenyon J.A., Xue H., Miller M.A., De Luca A., Miller D.M. et al.: "Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SOD mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy". Gynecol. Oncol., 2008, 110, 256.
6. Salvador S., Rempel A., Soslow R.A., Gilks B., Huntsman D., Miller D.: "Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma". Gynecol. Oncol., 2008, 110, 408.
7. Folkins A.K., Jarboe E.A., Saleemuddin A., Lee Y., Callahan M.J., Drapkin R. et al.: "A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations". Gynecol. Oncol., 2008, 109, 168.
8. Tone A.A., Begley H., Sharma M., Murphy J., Rosen B., Brown T.J. et al:. "Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma". Clin. Cancer Res., 2008, 14, 4067.
9. Pengetnze Y., Steed M., Roby K.F., Terranova P.F., Taylor C.C.: "Src tyrosine kinase promotes survival and resistance to chemotherapeutics in a mouse ovarian cancer cell line". Biochem. Biophys. Res. Commun., 2003, 309, 377. (Pubitemid 37025902)
10. Greenaway J., Moorehead R., Shaw P., Petrik J.: "Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer". Gynecol. Oncol., 2008, 108, 385. (Pubitemid 351174296)
11. Abedini M.R., Muller E.J., Brun J., Bergeron R., Gray D.A., Tsang B.K.: "Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells". Cancer Res., 2008, 68, 4511.
12. Lane D., Cartier A., Rancourt C., Piche A.: "Cell detachment modulates TRAIL resistance in ovarian cancer cells by downregulating the phosphatidylinositol 3-kinase/Akt pathway". Int. J. Gynecol. Cancer, 2008, 18, 670. (Pubitemid 352020151)
13. Lane D., Robert V., Grondin R., Rancourt C., Piche A.: "Malignant ascites protect against TRAIL-induced apoptosis by activating the PI3K/Akt pathway in human ovarian carcinoma cells". Int. J. Cancer, 2007, 121, 1227. (Pubitemid 47293789)
14. Bayani J., Paderova J., Murphy J., Rosen B., Zielenska M., Squire J.A.: "Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer. Neoplasia, 2008, 10, 1057.
15. Prasad M., Bernardini M., Tsalenko A., Marrano P., Paderova J., Lee C.H. et al.: "High definition cytogenetics and oligonucleotide aCGH analyses of cisplatin-resistant ovarian cancer cells". Genes Chromosomes Cancer, 2008, 47, 427.
16. Klinck R., Bramard A., Inkel L., Dufresne-Martin G., Gervais-Bird J., Madden R. et al.: "Multiple alternative splicing markers for ovarian cancer". Cancer Res., 2008, 68, 657. (Pubitemid 351206740)
17. Nelson B.H.: "The impact of T-cell immunity on ovarian cancer outcomes". Immunol Rev., 2008, 222, 101.
18. Yang T., Wall E.M., Milne K., Theiss P., Watson P., Nelson B.H.: "CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism". Clin. Cancer Res., 2007, 13, 7172. (Pubitemid 350276904)